- Home
- IMCR vs LADR Comparison
IMCR vs LADR Comparison
Compare IMCR & LADR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IMCR | LADR |
|---|---|---|
| Founded | 2008 | 2008 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.3B |
| IPO Year | 2016 | 2013 |
Fundamental Metrics
Financial Performance| Metric | IMCR | LADR |
|---|---|---|
| Price | $30.88 | $10.38 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 2 |
| Target Price | ★ $66.33 | $12.25 |
| AVG Volume (30 Days) | 556.7K | ★ 874.0K |
| Earning Date | 05-07-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 8.98% |
| EPS Growth | ★ 30.39 | N/A |
| EPS | ★ 0.25 | 0.02 |
| Revenue | ★ $249,428,000.00 | N/A |
| Revenue This Year | $14.57 | $31.66 |
| Revenue Next Year | $8.21 | $16.92 |
| P/E Ratio | ★ $122.16 | $508.50 |
| Revenue Growth | ★ 43.05 | N/A |
| 52 Week Low | $27.56 | $9.61 |
| 52 Week High | $40.71 | $11.92 |
Technical Indicators
Market Signals| Indicator | IMCR | LADR |
|---|---|---|
| Relative Strength Index (RSI) | 61.86 | 55.22 |
| Support Level | $27.66 | $9.94 |
| Resistance Level | $31.56 | $10.46 |
| Average True Range (ATR) | 1.12 | 0.19 |
| MACD | 0.28 | 0.01 |
| Stochastic Oscillator | 73.84 | 65.48 |
Price Performance
Historical ComparisonAbout IMCR Immunocore Holdings plc
Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.
About LADR Ladder Capital Corp
Ladder Capital Corp is an internally-managed real estate investment trust that is in commercial real estate finance. The company originates and invests in a diverse portfolio of commercial real estate and real estate-related assets, focusing on senior secured assets. The company's investment activities include: (i) Primary business of originating senior first mortgage fixed and floating rate loans collateralized by commercial real estate with flexible loan structures; (ii) owning and operating commercial real estate, including net leased commercial properties; and (iii) investing in investment-grade securities secured by first mortgage loans on commercial real estate. The company has three reportable segments: Loans, which derive maximum revenue; Securities; and Real Estate.